Humana, CVS Health In the Running to Acquire Cano Health - Reports

Go back to Humana, CVS Health In the Running to Acquire Cano Health - Reports

Citi Reiterates $7 PT on Cano Health (CANO), Says Takeout Could Be Worth $14 on Roughly 2x Revenue

September 23, 2022 12:18 PM EDT

Citi analyst Jason Cassorla reiterated a Buy rating and $7.00 price target on Cano Health (NYSE: CANO).

The analyst comments "Another Takeout Headline Not Surprising: Multiple headlines over the past ~six months have suggested CANO could potentially be acquired. To this end, CANO traded at ~1.0x our 2023E revenue at an unaffected price of $6.31 (September 21st close), which compares to its SPAC merger multiple at ~3x forward revenue, and other recent deals in the space including AMZNs... More

CVS Health (CVS) Said to Consider Potential Bid for Cano Health (CANO) - Bloomberg

September 22, 2022 3:28 PM EDT

CVS Health (NYSE: CVS) Said to Consider Potential Bid for Cano Health (NYSE: CANO) - Bloomberg

... More

CVS Health (CVS) Declares $0.55 Quarterly Dividend; 2.2% Yield

September 22, 2022 5:56 AM EDT

CVS Health (NYSE: CVS) declared a quarterly dividend of $0.55 per share, or $2.2 annualized.

The dividend will be payable on November 1, 2022, to stockholders of record on October 21, 2022, with an ex-dividend date of October 20, 2022.

The annual yield on the dividend is 2.2... More

CVS, Walmart reach $147.5 million opioid settlement with West Virginia

September 20, 2022 3:31 PM EDT

By Dietrich Knauth

(Reuters) -CVS Health Corp and Walmart Inc have agreed to pay $147.5 million to settle West Virginia's claims over their alleged roles in the state's opioid crisis, state attorney general Patrick Morrisey said Tuesday.

CVS agreed to pay $82.5 million and Walmart agreed to pay approximately $65 million, according to the state.

West Virginia had been prepared to proceed to trial on Sept. 26 against the two companies, as well as Walgreens Boots Alliance.

The state had accused the pharmacy chains of fueling the deadly opioid epidemic through their allegedly lax oversight of prescription pills sold in the... More